InfuSystem Holdings (INFU) Return on Capital Employed Growth (3y) (2014 - 2026)
InfuSystem Holdings (INFU) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -236.00 |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 281.00 |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 446.00 |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -433.00 |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 1,627.00 |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | -62.00 |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | - |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 370.00 |
| 10 | InfuSystem Holdings | 242.86 Mn | 241.90 Mn | 21.41 Mn | 1,253.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,253.00 |
| Mar 31, 2026 | 1,325.00 |
| Dec 31, 2025 | 1,303.00 |
| Sep 30, 2025 | 1,075.00 |
| Jun 30, 2025 | 1,074.00 |
| Mar 31, 2025 | 780.00 |
| Dec 31, 2024 | 455.00 |
| Sep 30, 2024 | 336.00 |
| Jun 30, 2024 | -321.00 |
| Mar 31, 2024 | -797.00 |
| Dec 31, 2023 | -873.00 |
| Sep 30, 2023 | -1,019.00 |
| Jun 30, 2023 | -841.00 |
| Mar 31, 2023 | -458.00 |
| Dec 31, 2022 | -426.00 |
| Sep 30, 2022 | -180.00 |
| Jun 30, 2022 | -7.00 |
| Mar 31, 2022 | 295.00 |
| Dec 31, 2021 | 254.00 |
| Sep 30, 2021 | 487.00 |